Aeglea BioTherapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,656.00
33,142.00
63,502.00
50,299.00
74,513
Total Accounts Receivable
-
1,697.00
1,215.00
3,078.00
300
Other Current Assets
74.00
912.00
1,707.00
1,614.00
1,858
Total Current Assets
2,730.00
35,751.00
66,424.00
54,991.00
76,671
Net Property, Plant & Equipment
162.00
348.00
599.00
854.00
1,018
Other Assets
38.00
2,555.00
40.00
232.00
50
Total Assets
2,930.00
38,654.00
67,063.00
56,077.00
77,739
Accounts Payable
345.00
176.00
168.00
389.00
Other Current Liabilities
713.00
2,347.00
3,797.00
5,240.00
Total Current Liabilities
1,058.00
2,523.00
3,965.00
5,629.00
Other Liabilities
-
27.00
132.00
111.00
Total Liabilities
1,058.00
2,550.00
4,097.00
5,740.00
Common Equity (Total)
11,473.00
22,207.00
62,966.00
50,337.00
Total Shareholders' Equity
1,872.00
36,104.00
62,966.00
50,337.00
Total Equity
1,872.00
36,104.00
62,966.00
50,337.00
Liabilities & Shareholders' Equity
2,930.00
38,654.00
67,063.00
56,077.00
Preferred Stock (Carrying Value)
13,345.00
58,311.00
-
-
About Aeglea BioTherapeutics
View Profile
